Medcura Overview

Founded 2007
Status Private
Employees 12
Latest Deal Type Later Stage VC
Latest Deal Amount $1.56M
Latest Deal Amount
Investors 9

Medcura General Information


Developer of a clinical-stage medical device platform designed to develop a novel line of hemostatic and wound treatment products. The company's platform develops a broad range of hemostatic and wound treatment products, including bandages for the treatment of routine cuts and scrapes, foams and putties for traumatic and military injuries as well as surgical gels and powders, enabling physicians to access products that are engineered to stop bleeding quickly and conveniently.

Contact Information

Formerly Known As
Remedium Technologies, gel-e
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Other Industries
Other Healthcare Technology Systems
Primary Office
  • 5650 Rivertech Court
  • Suite S
  • Riverdale Park, MD 20737
  • United States
+1 (301) 000-0000

Medcura Timeline

Financing RoundCaptured Employee CountEstimated Employee Growth
Want detailed data on 2M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Medcura Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
9. Later Stage VC 02-Jul-2018 $1.56M 00.000 Completed Generating Revenue
8. Grant 19-Feb-2018 0000 00.000 Completed Generating Revenue
7. Later Stage VC 13-Jul-2017 00.00 00.000 Completed Generating Revenue
6. Later Stage VC 01-Nov-2016 00.000 00.000 00.000 Completed Generating Revenue
5. Accelerator/Incubator 26-Feb-2014 00000 00000 Completed Generating Revenue
4. Grant 00000 0000 Completed Generating Revenue
3. Grant 18-Jan-2013 00000 0000 Completed Generating Revenue
2. Grant 18-Nov-2011 $150K $75K Completed Startup
1. Early Stage VC 05-Sep-2010 $75K $75K Completed Startup

Medcura Cap Table

To view Medcura‘s complete cap table, request access >>
Stock # of Shares
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Seed 0,000,000 00.000000 00.0 00.0 00 00.0 00.000

Medcura Competitors (2)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing
Imbed Biosciences Venture Capital-Backed Fitchburg, WI 00 00.000 00000000000 00.000
00000000000 Venture Capital-Backed Maple Grove, MN 00 000.00 00000000000 000.00

Medcura Executive Team (6)

Name Title Board Seat Contact Info
Larry Tiffany JD Chief Executive Officer and Director
Rich Vincent Chief Financial Officer
Matthew Dowling Ph.D Co-Founder, Chief Scientific Officer & Board Member
Srinivasa Raghavan Ph.D Co-Founder & Advisor

2 Former Executives

Medcura Board Members (3)

Name Representing Role Since
Alexander Arrow Self Board Member 000 0000
James Buck Self Board Member 000 0000
Matthew Dowling Ph.D Medcura Co-Founder, Chief Scientific Officer & Board Member 000 0000

Medcura Investors (9)

To view Medcura‘s full investor history, request access >>
Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Aubrey Capital Venture Capital Minority 000 0000 000000 0
Delaware Crossing Investor Group Angel Group 000 0000 000000 0
United States Department of Defense Government 000 0000 000000 0
UM Ventures Venture Capital Minority 000 0000 000000 0
Robin Hood Ventures Angel Group Minority 000 0000 000000 0

Ready to get started?

Request a free trial